Important considerations before combining these medications include: Absolute contraindications : The combination should be avoided in patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, during or within 14 days of MAOI use, personal/family history of MTC or MEN2, pregnancy, breastfeeding, or severe gastrointestinal disease Cardiovascular risk assessment : Phentermine increases heart rate and blood pressure, which requires careful monitoring with baseline and follow-up measurements of vital signs and possibly EKG if cardiac history exists Gastrointestinal tolerability : Tirzepatide commonly causes nausea, vomiting, and diarrhea, which may be compounded by phentermine's effects Medication interactions : Tirzepatide may reduce the effectiveness of oral contraceptives during initiation and dose escalation
1 month supply of the HCG medication
Injection site reactions redness, swelling, itching are consistent with class effects seen with authorised GLP-1-based agents such as semaglutide and tirzepatide
Injectables vs
Its naturally available from animal products, including fish, meat, poultry, eggs, milk, and milk products but its not usually present in plant foods
The relationship between MOTS-c and metformin deserves careful attention